Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2421603

COc1cccc(C(=O)Nc2ccc(N3CCC(N4CCCC4C)C3)c(C)c2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 11/20 0.64
MAPT P10636 4/20 0.49
LMNA P02545 3/20 0.46
RAB9A P51151 2/20 0.46
QSOX1 O00391 1/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
GFER P55789 1/20 0.44
KCNH2 Q12809 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2425325 0.94 HRH3 (0.68) HRH3MAPTLMNARAB9AQSOX1
Trifluoroacetic Acid SCHEMBL2419746 0.91 HRH3 (0.64) HRH3MAPTKCNH2TP53
Trifluoroacetic Acid SCHEMBL2421907 0.90 HRH3 (0.59) HRH3MAPTSMN1; SMN2TDP1KCNH2
Trifluoroacetic Acid SCHEMBL2425145 0.89 HRH3 (0.59) HRH3TDP1KCNH2
Trifluoroacetic Acid SCHEMBL2426736 0.89 HRH3 (0.62) HRH3MAPTLMNARAB9AQSOX1
Trifluoroacetic Acid SCHEMBL2420806 0.88 HRH3 (0.57) HRH3MAPTRAB9ASMN1; SMN2TDP1
SCHEMBL2419835 0.86 HRH3 (0.61) HRH3RAB9AKCNH2
SCHEMBL2422678 0.85 HRH3 (0.68) HRH3MAPTRAB9AALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL2421645 0.85 HRH3 (0.58) HRH3MAPTLMNARAB9ANPC1
SCHEMBL13266071 0.85 HRH3 (0.73) HRH3MAPTALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618159-B2 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof SANOFI (FR) 2013-12-31 US disclosed
EP-2212282-B1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2011-09-21 EP disclosed
US-20100173897-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173897-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF HRH3, HRH4, CNR1 HRH3 1/4885MAPT 1607/4885LMNA 3317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.